First National Trust’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,412
| Closed | -$238K | – | 380 |
|
|
2023
Q3 | $238K | Hold |
3,412
| – | – | 0.01% | 339 |
|
|
2023
Q2 | $245K | Sell |
3,412
-1,000
| -23% | -$71.9K | 0.01% | 336 |
|
|
2023
Q1 | $272K | Sell |
4,412
-2,900
| -40% | -$179K | 0.01% | 327 |
|
|
2022
Q4 | $564K | Hold |
7,312
| – | – | 0.03% | 247 |
|
|
2022
Q3 | $326K | Hold |
7,312
| – | – | 0.02% | 292 |
|
|
2022
Q2 | $280K | Hold |
7,312
| – | – | 0.02% | 310 |
|
|
2022
Q1 | $303K | Hold |
7,312
| – | – | 0.02% | 321 |
|
|
2021
Q4 | $276K | Hold |
7,312
| – | – | 0.01% | 330 |
|
|
2021
Q3 | $241K | Hold |
7,312
| – | – | 0.01% | 325 |
|
|
2021
Q2 | $493K | Hold |
7,312
| – | – | 0.03% | 262 |
|
|
2021
Q1 | $414K | Buy |
+7,312
| New | +$414K | 0.03% | 271 |
|